Cough and cold medication in children: a public health concern

A R Norazida1, S Sivasampu2, C L Teng3

  • 1Ministry of Health Malaysia, Clinical Research Centre, Healthcare Statistics Unit, Malaysia. sheamini@crc.gov.my.

Insights

Cough and cold medicine (CCM) prescriptions are common in children, with nearly half of those under 12 receiving them. This is particularly concerning for children under two years old, highlighting a need for stricter monitoring.

Area of Science:

  • Pediatric Pharmacology
  • Public Health
  • Pharmaceutical Policy

Background:

  • Indiscriminate use of cough and cold medicines (CCMs) in children poses a significant public health concern.
  • Evaluating CCM prescription patterns in primary care is crucial for understanding usage and potential risks.

Purpose of the Study:

  • To analyze the prescription patterns of cough and cold medicines (CCMs) in children aged 12 years and below within a primary care setting.
  • To identify the prevalence and characteristics of CCM prescriptions in pediatric populations.

Main Methods:

  • Analysis of prescription data from the National Medical Care Survey (NMCS) 2010.
  • Inclusion of children aged 12 years and below from both public and private primary care clinics in Malaysia.
  • Cross-sectional survey data collected between December 2009 and April 2010.

Main Results:

  • Nearly half (49%) of 3574 pediatric encounters involved CCM prescriptions, totaling 2402 CCMs.
  • CCMs were prescribed at a rate of 1.3-1.4 per encounter in public and private clinics, respectively.
  • A notable 23% of CCMs were prescribed to children under two years old, with many receiving multiple medications per visit.

Conclusions:

  • The high prevalence of CCM prescriptions in children, especially those under two, is a significant concern due to safety and adverse effect risks.
  • There is a clear need for firmer policies and enhanced monitoring of CCM prescriptions for pediatric patients.
  • The findings underscore the importance of judicious prescribing practices for CCMs in young children.
Abstract

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
915
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
1.0K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K